Fukumoto Masayuki, Soyama Akihiko, Miyamoto Daisuke, Hara Takanobu, Matsushima Hajime, Imamura Hajime, Yamashita Mampei, Adachi Tomohiko, Kanetaka Kengo, Eguchi Susumu
Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501 Japan.
Regen Ther. 2025 May 9;30:1-8. doi: 10.1016/j.reth.2025.04.015. eCollection 2025 Dec.
We have explored chemically induced liver progenitors (CLiP) as a potential therapeutic agent for liver diseases because their proliferative capacity . Therefore, we hypothesized the potential treatment with CLiP transplantation (Tx) could be effective and be enhanced with liver regenerative stimulus for metabolic liver diseases.
Male Sprague Dawley rats were used for mature hepatocytes (HEP) isolation to induce CLiP using 3 small molecules cocktail (ROCK-inhibitor, TGF beta-1 inhibitor, GSK3 inhibitor). Harvested rat CLiP (1 × 10) were transplanted to the posterior lobe of the liver (30 % of whole liver) of Nagase analbuminemic rats (NAR) through portal vein injection. One week later, portal venous branch to non-transplanted lobe was ligated to induce liver regeneration in CLiP bearing liver lobe (portal branch ligation: PBL). Only CLiP Tx or HEP Tx of same dose were used as control groups. Serial measurement of serum albumin level was measured by ELISA method. All NARs were subject to immunosuppression therapy using tacrolimus s.q. 3 days per week.
After HEP Tx especially with PBL, serum albumin level was significantly elevated. However, even with PBL, CLiP Tx group did not show significant increase in serum albumin. CLiP were surrounded by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) positive cells in portal veins suggesting that CLiP were exposed to the risk of innate immunity.
Although CLiP respond to growth factors and proliferate better than HEP , their behavior in response to liver regenerative stimulus were not similar to probably because of less immaturity of receptors and/or high immunogenicity as compared to HEP.
我们已探索化学诱导肝祖细胞(CLiP)作为肝病的一种潜在治疗剂,因为它们具有增殖能力。因此,我们假设CLiP移植(Tx)的潜在治疗可能有效,并且对于代谢性肝病,肝再生刺激可增强其疗效。
使用雄性Sprague Dawley大鼠分离成熟肝细胞(HEP),并用3种小分子混合物(ROCK抑制剂、TGFβ-1抑制剂、GSK3抑制剂)诱导CLiP。将收获的大鼠CLiP(1×10)通过门静脉注射移植到长谷无白蛋白血症大鼠(NAR)肝脏的后叶(全肝的30%)。一周后,结扎未移植叶的门静脉分支,以诱导携带CLiP的肝叶发生肝再生(门静脉分支结扎:PBL)。仅使用相同剂量的CLiP Tx或HEP Tx作为对照组。通过ELISA法连续测量血清白蛋白水平。所有NAR每周3天皮下使用他克莫司进行免疫抑制治疗。
HEP Tx后,尤其是PBL后,血清白蛋白水平显著升高。然而,即使进行PBL,CLiP Tx组的血清白蛋白也未显示出显著增加。门静脉中CLiP被肿瘤坏死因子相关凋亡诱导配体(TRAIL)阳性细胞包围,提示CLiP面临先天免疫风险。
尽管CLiP对生长因子有反应且比HEP增殖更好,但其对肝再生刺激的反应行为可能与HEP不同,这可能是因为与HEP相比,其受体成熟度较低和/或免疫原性较高。